n-(1-methyl-2-phenylethyl)adenosine has been researched along with cytidylyl-3',5'-adenosine in 1 studies
| Studies (n-(1-methyl-2-phenylethyl)adenosine) | Trials (n-(1-methyl-2-phenylethyl)adenosine) | Recent Studies (post-2010) (n-(1-methyl-2-phenylethyl)adenosine) | Studies (cytidylyl-3',5'-adenosine) | Trials (cytidylyl-3',5'-adenosine) | Recent Studies (post-2010) (cytidylyl-3',5'-adenosine) |
|---|---|---|---|---|---|
| 134 | 0 | 4 | 37 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hourani, SM; Payne, SL; Prentice, DJ | 1 |
1 other study(ies) available for n-(1-methyl-2-phenylethyl)adenosine and cytidylyl-3',5'-adenosine
| Article | Year |
|---|---|
Activation of two sites by adenosine receptor agonists to cause relaxation in rat isolated mesenteric artery.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Anti-Arrhythmia Agents; Dinucleoside Phosphates; Dose-Response Relationship, Drug; Male; Mesenteric Arteries; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Theophylline; Triazines; Triazoles; Vasodilation; Vasodilator Agents | 1997 |